Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240821 | 12524082 | 1 | I | 20150407 | 20160624 | 20160704 | 20160704 | EXP | JP-009507513-1606JPN013558 | MERCK | 78.00 | YR | M | Y | 0.00000 | 20160704 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240821 | 12524082 | 1 | PS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 800 MG DAILY, DIVIDED DOSE FREQUENCY UNKNOWN | 22145 | 800 | MG | TABLET | QD | ||||||
| 125240821 | 12524082 | 2 | SS | EPZICOM | ABACAVIR SULFATELAMIVUDINE | 1 | 1 TABLET, QD | 0 | 1 | DF | TABLET | QD | |||||||
| 125240821 | 12524082 | 3 | C | OLOPATADINE HYDROCHLORIDE. | OLOPATADINE HYDROCHLORIDE | 1 | Oral | 5 MG, BID | U | 0 | 5 | MG | TABLET | BID | |||||
| 125240821 | 12524082 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD | |||||
| 125240821 | 12524082 | 5 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD | |||||
| 125240821 | 12524082 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125240821 | 12524082 | 1 | HIV infection |
| 125240821 | 12524082 | 2 | HIV infection |
| 125240821 | 12524082 | 3 | Seborrhoeic dermatitis |
| 125240821 | 12524082 | 4 | Hypertension |
| 125240821 | 12524082 | 5 | Hypertension |
| 125240821 | 12524082 | 6 | Renal disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125240821 | 12524082 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125240821 | 12524082 | Dyslipidaemia | |
| 125240821 | 12524082 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125240821 | 12524082 | 1 | 20130611 | 0 | ||
| 125240821 | 12524082 | 2 | 20130611 | 0 | ||
| 125240821 | 12524082 | 6 | 20151218 | 0 |